Clinical Trials Browser

Phase NA × OTHER × gilteritinib × Clear all

NCT07131059 2025-08-20

MRD-positive AML Clinical Study

Phase NA Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT06992934 2025-08-03

TARGETALLO

Phase NA Not yet recruiting

Other hematologic neoplasm

Hematologic Neoplasms